Specific considerations must be considered in the treatment of children and adolescents with IBD. Thus, GMA could play an important role in the treatment of some specific pediatric IBD patients in whom reinforcement, safer or longer-term outcomes are needed. In this webinar, Dr. J.M. de Carpi makes an exhaustive review of the rationale for the efficacy of GMA in the treatment of IBD as well as the existing evidence for its use in the pediatric population and a proposal of patient profiles in which GMA may be useful based on his own experience in clinical practice.
PRACTICAL SCENARIOS FOR THE USE OF GRANULOCYTE AND MONOCYTE SELECTIVE APHERESIS (GMA) IN PEDIATRIC IBD
February 25, 2023
Contact UsFor more informationContact Us